This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Profectus Biosciences, Inc.
Drug Names(s): GENEVAX IL-12 pDNA adjuvant vaccine
Description: GENEVAX IL-12 is a proprietary formulation of a plasmid DNA vector that expresses the p40 and p35 subunits of the human cytokine Interleukin-12 plus the anesthetic bupivacaine. In addition to its anesthetic properties, bupivacaine has been shown to significantly stabilize and enhance the efficiency of DNA vaccines.
GENEVAX IL-12 News
Additional information available to subscribers only: